Ondine Biomedical Inc. is the global leader in the development of innovative non-antibiotic therapies for the treatment and prevention of bacterial, fungal and viral infections. Ondine’s photodisinfection therapies represent potential non-antibiotic alternatives to a wide range of infections including periodontal disease, ventilator-associated pneumonia and chronic sinusitis. Ondine’s mission is to develop a broad product pipeline of proprietary anti-infective products, leveraging core strengths, product development expertise and strategic relationships.

Acquired Companies: Advanced Photodynamic Technologies, Inc.